Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,154	1,897	1,781	1,523	908.63	442.1
Other Revenue	20.01	14.62	17.54	11.12	12.35	4.84
Revenue	2,174	1,912	1,799	1,534	920.98	446.94
Revenue Growth (YoY)	20.29%	6.29%	17.23%	66.61%	106.07%	18.90%
Cost of Revenue	1,281	1,187	1,122	905.42	507.85	182.77
Gross Profit	892.7	724.64	676.98	629.03	413.14	264.17
Selling, General & Admin	717.84	649.1	567.58	458.23	267.36	187.22
Operating Expenses	717.84	649.1	567.58	458.23	267.36	187.22
Operating Income	174.86	75.53	109.4	170.8	145.77	76.95
Interest Expense	-20.33	-19.85	-25.76	-23.34	-8.01	-1.14
Earnings From Equity Investments	-1.92	-1.59	-2.27	-0.77	-0.08	-0.16
EBT Excluding Unusual Items	152.61	54.1	81.37	146.69	137.68	75.65
Pretax Income	152.61	54.1	81.37	146.69	137.68	75.65
Income Tax Expense	29.89	16.42	22.47	19.41	27.2	16.39
Earnings From Continuing Operations	122.72	37.68	58.9	127.29	110.48	59.26
Minority Interest in Earnings	-11.37	-0.4	-8.11	-8.4	-5.27	-6.72
Net Income	111.34	37.28	50.79	118.88	105.22	52.54
Net Income to Common	111.34	37.28	50.79	118.88	105.22	52.54
Net Income Growth	887.93%	-26.60%	-57.28%	12.99%	100.27%	20.85%
Shares Outstanding (Basic)	605	605	605	532	475	470
Shares Outstanding (Diluted)	605	605	605	532	475	470
Shares Change (YoY)	-	-	13.78%	11.97%	1.05%	31.92%
EPS (Basic)	0.18	0.06	0.08	0.22	0.22	0.11
EPS (Diluted)	0.18	0.06	0.08	0.22	0.22	0.11
EPS Growth	887.98%	-26.60%	-62.45%	0.91%	98.19%	-8.39%
Free Cash Flow	115.43	-59.59	14.96	115.72	-265.73	-21.27
Free Cash Flow Per Share	0.19	-0.10	0.03	0.22	-0.56	-0.04
Dividend Per Share	-	-	0.021	0.111	-	0.010
Dividend Growth	-	-	-80.69%	-	-	-87.33%
Gross Margin	41.07%	37.90%	37.64%	40.99%	44.86%	59.11%
Operating Margin	8.04%	3.95%	6.08%	11.13%	15.83%	17.22%
Profit Margin	5.12%	1.95%	2.82%	7.75%	11.42%	11.76%
Free Cash Flow Margin	5.31%	-3.12%	0.83%	7.54%	-28.85%	-4.76%
EBITDA	218.45	138.35	167.66	208.7	170.85	82.14
EBITDA Margin	10.05%	7.24%	9.32%	13.60%	18.55%	18.38%
D&A For EBITDA	43.59	62.82	58.25	37.9	25.08	5.19
EBIT	174.86	75.53	109.4	170.8	145.77	76.95
EBIT Margin	8.04%	3.95%	6.08%	11.13%	15.83%	17.22%
Effective Tax Rate	19.59%	30.35%	27.61%	13.23%	19.75%	21.67%
Revenue as Reported	2,174	1,912	1,799	1,534	920.98	446.94
Advertising Expenses	-	93.14	70.61	31.91	41.13	36.63

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.